Prescribing Evidence: The Effectiveness and Safety of New Drugs

被引：0

作者：

Fugh-Berman, Adriane ^{[1
]}

机构：

[1] Georgetown Univ, Med Ctr, Washington, DC 20007 USA

来源：

AMERICAN FAMILY PHYSICIAN | 2010年 / 82卷 / 01期

关键词：

MEDICATIONS;

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：37 / 37

页数：1

共 6 条

[1] A physician survey on generic drugs and substitution or critical dose medications [J].

Banahan, BF ;

Kolassa, EM .

ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (18) :2080-2088

[2]

*KAIS FAM FDN, PRESCR DRUG TRENDS 2

[3] Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease A Systematic Review and Meta-analysis [J].

Kesselheim, Aaron S. ;

Misono, Alexander S. ;

Lee, Joy L. ;

Stedman, Margaret R. ;

Brookhart, M. Alan ;

Choudhry, Niteesh K. ;

Shrank, William H. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (21) :2514-2526

[4] Timing of new black box warnings and withdrawals for prescription medications [J].

Lasser, KE ;

Allen, PD ;

Woolhandler, SJ ;

Himmelstein, DU ;

Wolfe, SN ;

Bor, DH .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (17) :2215-2220

[5] Are novel drugs more risky for patients than less novel drugs? [J].

Olson, MK .

JOURNAL OF HEALTH ECONOMICS, 2004, 23 (06) :1135-1158

[6]

Pegler S, 2010, AM FAM PHYSICIAN, V82, P53

← 1 →